CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeeking Alpha • 09/09/25
CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?Zacks Investment Research • 08/28/25
CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the StockZacks Investment Research • 08/21/25
Here's How This Forgotten Healthcare Stock Could Generate Life-Changing ReturnsThe Motley Fool • 08/17/25
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next DecadeBenzinga • 08/14/25
Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?Zacks Investment Research • 08/12/25
CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy AdoptionZacks Investment Research • 08/05/25
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/04/25
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial ResultsGlobeNewsWire • 08/04/25
Should You Invest in CRISPR Therapeutics (CRSP) Based on Bullish Wall Street Views?Zacks Investment Research • 07/30/25
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/28/25
Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something BigSeeking Alpha • 07/23/25
Nearly 89% of Companies are Seeing Insider Selling, But these 3 are Seeing Substantial Buying24/7 Wall Street • 07/22/25
Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views?Zacks Investment Research • 07/14/25